
Gynecology for Cancer Survivors & At-Risk Women
On this page
The UCSF Gynecology Center for Cancer Survivors and At-Risk Women offers innovative, compassionate gynecologic care for women who have completed cancer treatment or who are at high risk for developing cancer. We are a joint program of UCSF's women's health and cancer programs.
We address symptoms and issues such as:
- Chemotherapy-induced menopause
- Decisions about oophorectomy (ovary removal) for breast cancer patients and women at high risk for breast cancer
- Fertility preservation and reproductive concerns after breast cancer
- Hot flashes
- Low libido and sexual side effects
- Side effects of breast cancer drugs
- Sleep disturbances
- Vaginal dryness
In addition to caring for patients, we provide guidance to other gynecologists on managing uterine cancer risk and other side effects of hormonal therapies used to treat breast cancer.
The UCSF Gynecology Center for Cancer Survivors and At-Risk Women offers innovative, compassionate gynecologic care for women who have completed cancer treatment or who are at high risk for developing cancer. We are a joint program of UCSF's women's health and cancer programs.
We address symptoms and issues such as:
- Chemotherapy-induced menopause
- Decisions about oophorectomy (ovary removal) for breast cancer patients and women at high risk for breast cancer
- Fertility preservation and reproductive concerns after breast cancer
- Hot flashes
- Low libido and sexual side effects
- Side effects of breast cancer drugs
- Sleep disturbances
- Vaginal dryness
In addition to caring for patients, we provide guidance to other gynecologists on managing uterine cancer risk and other side effects of hormonal therapies used to treat breast cancer.
Providers

Mindy Goldman, MD
Obstetrics and Gynecology • Gynecology
Felicia C. Lester, MD, MPH
Obstetrics and Gynecology • Complex Family Planning
Tami Rowen, MD, MS
Obstetrics and Gynecology • Gynecology
Robin Litt, NP
Breast Medical Oncology
Related services
Related conditions & treatments
Conditions
- Infertility After Cancer Treatment
- Vasomotor Symptoms
- Cancer-Related Sexual Concerns
- Breast Cancer
- Gynecologic Cancer
Treatments
- Gynecologic Cancer Care
- Fertility Preservation
- Hormone Replacement Therapy
- Breast Cancer Follow-Up
Clinical trials
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as TreatmentOpens in a new window
Recruiting
Fraction of patients remaining on active surveillance at 7 months compared to controlAvelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast CancerOpens in a new window
Recruiting
BORR is defined as the percentage of patients achieving complete response (CR) or partial response (PR) by Response Evaluation Criteria in Solid Tumors…Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical TrialOpens in a new window
Recruiting
Progression-Free Survival (PFS) is defined as the time from the first dose of study treatment to the date of disease progression as assessed by Response…Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive SubjectsOpens in a new window
Recruiting
IBCFS is defined as the time from the first dose of study medication until the date of ipsilateral invasive breast cancer recurrence, ipsilateral…





